Sanofi/Regeneron’s Esophagitis Data Add To Dupixent’s Winning Streak

 
• By Alaric DeArment
  
Sanofi and Regeneron announced results from a Phase III trial of Dupixent in eosinophilic esophagitis • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Therapeutic Category